Dara Burdette Email

Executive Director, Discovery Research . Tempest Therapeutics

Current Roles

Employees:
33
Revenue:
$5.1M
About
Tempest Therapeutics is a clinical-stage biotechnology company advancing small molecule therapeutics that modulate anti-tumor immunity pathways. Tempest has a balanced and deep pipeline consisting of first-in-class and best-in-class small molecule therapeutics, which modulate distinct immune response pathways relevant to mounting an effective anti-tumor response. The molecules were developed by Inception Sciences, a Versant Ventures affiliated drug discovery engine. Tempest has assembled a highly experienced team of small molecule and immuno-oncology drug developers to advance these programs to the clinic across diverse cancers representing significant unmet medical need. Tempest is backed by a syndicate of leading US and China based venture capital firms.
Tempest Therapeutics Address
7000 Shoreline Court
San Francisco, CA
United States
Tempest Therapeutics Email

Past Companies

TempestExecutive Director, Discovery Research
Tempest TherapeuticsSenior Director, Discovery Research
Gilead SciencesSenior Research Scientist II

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.